Longboard Pharmaceuticals, Inc. – NASDAQ:LBPH
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 17 hours
Longboard Pharmaceuticals stock price monthly change
+93.94%
month
Longboard Pharmaceuticals stock price quarterly change
+99.19%
quarter
Longboard Pharmaceuticals stock price yearly change
+322.36%
year
Longboard Pharmaceuticals key metrics
Market Cap | 2.34B |
Enterprise value | 81.46M |
P/E | -1.71 |
EV/Sales | N/A |
EV/EBITDA | -1.89 |
Price/Sales | N/A |
Price/Book | 1.48 |
PEG ratio | 0.05 |
EPS | -2.25 |
Revenue | N/A |
EBITDA | -62.90M |
Income | -57.95M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeLongboard Pharmaceuticals stock price history
Longboard Pharmaceuticals stock forecast
Longboard Pharmaceuticals financial statements
Average Price Target
$65
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 0 | -14.99M | |
|---|---|---|---|
| Sep 2023 | 0 | -12.93M | |
| Dec 2023 | 8K | -15.03M | -187912.5% |
| Mar 2024 | 0 | -14.98M |
| 2024-02-07 | -0.6 | -0.62 |
|---|
| Jun 2023 | 66223000 | 8.11M | 12.25% |
|---|---|---|---|
| Sep 2023 | 58864000 | 6.82M | 11.59% |
| Dec 2023 | 50697000 | 9.77M | 19.28% |
| Mar 2024 | 327665000 | 13.95M | 4.26% |
| Jun 2023 | -13.45M | 7.96M | -125K |
|---|---|---|---|
| Sep 2023 | -13.28M | 11.74M | 5.94M |
| Dec 2023 | -11.02M | -1.56M | 3.01M |
| Mar 2024 | -15.17M | -230.91M | 286.40M |
Longboard Pharmaceuticals alternative data
| Aug 2023 | 32 |
|---|---|
| Sep 2023 | 32 |
| Oct 2023 | 32 |
| Nov 2023 | 32 |
| Dec 2023 | 32 |
| Jan 2024 | 32 |
| Feb 2024 | 32 |
| Mar 2024 | 50 |
| Apr 2024 | 50 |
| May 2024 | 50 |
| Jun 2024 | 50 |
| Jul 2024 | 50 |
Longboard Pharmaceuticals other data
26.60%
-15.75%
of LBPH is owned by hedge funds
4.56M
-2.71M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Jan 2024 | 0 | 3978540 |
| Jun 2024 | 0 | 100 |
| Aug 2024 | 0 | 16667 |
| Sep 2024 | 0 | 16666 |
| Oct 2024 | 0 | 16667 |
| Quarter | Transcript |
|---|---|
| Q4 2022 2 Mar 2023 | Q4 2022 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
Mr. Kevin R. Lind (1976) Pres, Chief Executive Officer & Director | $506,920 |
Dr. Philip Perera (1953) Chief Medical Officer | $114,890 |
-
When is Longboard Pharmaceuticals's next earnings date?
Unfortunately, Longboard Pharmaceuticals's (LBPH) next earnings date is currently unknown.
-
Does Longboard Pharmaceuticals pay dividends?
No, Longboard Pharmaceuticals does not pay dividends.
-
How much money does Longboard Pharmaceuticals make?
Longboard Pharmaceuticals has a market capitalization of 2.34B. Longboard Pharmaceuticals made a loss 54.42M US dollars in net income (profit) last year or -$0.62 on an earnings per share basis.
-
What is Longboard Pharmaceuticals's stock symbol?
Longboard Pharmaceuticals, Inc. is traded on the NASDAQ under the ticker symbol "LBPH".
-
What is Longboard Pharmaceuticals's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Longboard Pharmaceuticals?
Shares of Longboard Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Longboard Pharmaceuticals's key executives?
Longboard Pharmaceuticals's management team includes the following people:
- Mr. Kevin R. Lind Pres, Chief Executive Officer & Director(age: 49, pay: $506,920)
- Dr. Philip Perera Chief Medical Officer(age: 72, pay: $114,890)
-
How many employees does Longboard Pharmaceuticals have?
As Jul 2024, Longboard Pharmaceuticals employs 50 workers.
-
When Longboard Pharmaceuticals went public?
Longboard Pharmaceuticals, Inc. is publicly traded company for more then 4 years since IPO on 12 Mar 2021.
-
What is Longboard Pharmaceuticals's official website?
The official website for Longboard Pharmaceuticals is longboardpharma.com.
-
Where are Longboard Pharmaceuticals's headquarters?
Longboard Pharmaceuticals is headquartered at 4275 Executive Square, La Jolla, CA.
-
How can i contact Longboard Pharmaceuticals?
Longboard Pharmaceuticals's mailing address is 4275 Executive Square, La Jolla, CA and company can be reached via phone at +61 95929775.
-
What is Longboard Pharmaceuticals stock forecast & price target?
Based on 4 Wall Street analysts` predicted price targets for Longboard Pharmaceuticals in the last 12 months, the avarage price target is $65. The average price target represents a null change from the last price of $0.
Longboard Pharmaceuticals company profile:
Longboard Pharmaceuticals, Inc.
longboardpharma.comExchange:
NASDAQ
Full time employees:
50
Industry:
Biotechnology
Sector:
Healthcare
Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical product candidates include LP659 and LP143, which focuses on developing therapies for multiple neurological diseases. The company was formerly known as Arena Neuroscience, Inc. and changed its name to Longboard Pharmaceuticals, Inc. in October 2020. Longboard Pharmaceuticals, Inc. was incorporated in 2020 and is based in La Jolla, California.
4275 Executive Square
La Jolla, CA 92037
La Jolla, CA 92037
CIK: 0001832168
ISIN: US54300N1037
CUSIP: 54300N103
